Mapping and definition of HLA class I and II serologic epitopes using an unbiased reverse engineering strategy.

[1]  D. Roelen,et al.  Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation , 2017, HLA.

[2]  A. Mulder,et al.  Usefulness of the Nonself-Self Algorithm of HLA Epitope Immunogenicity in the Specificity Analysis of Monospecific Antibodies Induced during Pregnancy , 2015, Front. Immunol..

[3]  P. Winn,et al.  Three-Dimensional Structural Modelling and Calculation of Electrostatic Potentials of HLA Bw4 and Bw6 Epitopes to Explain the Molecular Basis for Alloantibody Binding: Toward Predicting HLA Antigenicity and Immunogenicity , 2015, Transplantation.

[4]  J. Friedewald,et al.  Epitope Analysis of HLA-DQ Antigens: What Does the Antibody See? , 2014, Transplantation.

[5]  P. Terasaki,et al.  HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines. , 2013, Human immunology.

[6]  M. Marrari,et al.  16th IHIW: A Website for Antibody‐Defined HLA Epitope Registry , 2012, International journal of immunogenetics.

[7]  J. Bradley,et al.  High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. , 2011, Human immunology.

[8]  D. Tyan,et al.  14-OR Parallel C1q and IgG assays on single antigen beads reveal that the presence of IgM complement fixing antibodies can obscure clinically relevant IgG antibodies to the same allele , 2011 .

[9]  R. Duquesnoy,et al.  Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. , 2009, Tissue antigens.

[10]  P. Terasaki,et al.  Human Leukocyte Antigen Class I Epitopes: Update to 103 Total Epitopes, Including the C Locus , 2007, Transplantation.

[11]  P. Terasaki,et al.  HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. , 2007, Human immunology.

[12]  Rene J Duquesnoy,et al.  A structurally based approach to determine HLA compatibility at the humoral immune level. , 2006, Human immunology.

[13]  F. Claas,et al.  HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. , 2005, Human immunology.

[14]  René J Duquesnoy,et al.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. , 2002, Human immunology.

[15]  R. Duquesnoy,et al.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. , 2002, Human immunology.

[16]  L. Lanier,et al.  Follow the Leader: NK Cell Receptors for Classical and Nonclassical MHC Class I , 1998, Cell.

[17]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[18]  J. Bodmer,et al.  HLA-DR and -DQ epitopes and monoclonal antibody specificity. , 1989, Immunology today.

[19]  P. Terasaki,et al.  Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens. , 2009, Clinical transplants.

[20]  R. Duquesnoy,et al.  Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens. , 2009, Tissue antigens.